About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Patients Receiving Pelvic Radiation Therapy may Experience Diarrhea

by Bidita Debnath on September 24, 2013 at 7:54 PM
Font : A-A+

 Patients Receiving Pelvic Radiation Therapy may Experience Diarrhea

Patients receiving radiotherapy (RT) in the pelvic region for cancers can experience diarrhea, a negative side effect of radiation treatment.

Sulfasalazine, an oral tablet used to treat inflammation of the bowels, had been shown in a past trial of 31 patients to decrease diarrhea during pelvic RT (Killic 2001). Sulfasalazine does not reduce diarrhea, according to research presented today at the American Society of Radiation Oncology's (ASTRO's) 55th Annual Meeting. The study also determined that the medication may be associated with a higher risk of diarrhea than placebo.

Advertisement

The multi-institutional, randomized, double-blind, placebo-controlled phase III trial was conducted through the Alliance for Clinical Trials in Oncology (NCCTG/CALGB/ACOSOG) to evaluate the effectiveness of sulfasalazine versus placebo in the treatment of enteritis (inflammation of the intestinal tract) during pelvic RT (> 45 Gy). A total of 87 patients, with 78 patients evaluable for the primary endpoint and with evenly distributed baseline factors, were enrolled in the study at 24 institutions in the U.S. from 2011 until 2013. The patients received 1,000 mg sulfasalazine or placebo orally, twice each day during RT and for four weeks after RT. The primary endpoint was maximal severity of diarrhea, based on the Common Terminology Criteria for Adverse Events (CTCAE 4.0), during and up to six weeks after RT. A health care provider graded on a weekly basis the maximum severity and the duration of maximum severity of diarrhea, rectal bleeding, abdominal cramping, tenesmus (a sensation of incomplete defecation) and constipation. Patients completed bowel function questionnaires weekly during RT treatment, afterwards for six weeks and at 12 and 24 months post-RT. A two-sided, Wilcoxon rank-sum test was used to test the equality of the distributions of maximum diarrhea severity grades.

An interim analysis of the study revealed a statistically significant excess of grade ≥ 3 diarrhea (passing seven or more stools per day) in patients receiving sulfasalazine versus placebo (29 percent versus 11 percent, p=0.037). The study was halted in May 2013 when it was determined that it was unlikely for the sulfasalazine to indicate beneficial results.
Advertisement

"Although 2001 research had suggested a benefit for sulfasalazine, we were very surprised to find that patients receiving sulfasalazine experienced worse diarrhea than those receiving placebo," said Robert C. Miller, MD, MS, lead author of the study, a professor of radiation oncology at the Mayo Medical School and vice chairman of research in the department of radiation oncology at the Mayo Clinic in Rochester, Minn. "For the prevention of radiotherapy-related diarrhea, we now know that sulfasalazine will not benefit patients. This trial clearly illustrates the necessity for large, phase III, randomized controlled trials to understand which drugs and therapies will relieve the more negative side effects for patients receiving radiation therapy."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cholera Radiotherapy X-Ray Amoebic Dysentery Colo-rectal cancer - Management Hodgkins Lymphoma Non-Hodgkins Lymphoma Reiki and Pranic Healing Crohns Disease Radiation Hazards 

Recommended Reading
Scientists Find That Bacterium Uses Natural 'Thermometer' to Trigger Diarrheal Disease
How does the bacterium Shigella detect that it's in a human host? Shigella is the cause of a d...
Unicef Launches New Program to Contain Diarrhea Among Children in India
Unicef announced the launch of a new program costing around $5 million through which it hopes to ......
Phase I Study of Oral Vaccine Against Diarrhea Produces Positive Results
Researchers revealed that their placebo controlled phase I study of an oral, inactivated Escheric...
Probiotic Supplements may Not Prevent Antibiotic-associated Diarrhea in Elderly
A new study published in the journal The Lancet reveals that giving probiotic supplements to the ......
Amoebic Dysentery
Amoebic dysentery or amoebiasis is an infection of the intestine that causes diarrhoea most frequent...
Cholera
Cholera is an infection of the small intestine and is caused by the bacterium Vibrio cholerae....
Colo-rectal cancer - Management
Treatment for Colorectal Cancers may involve surgery,chemotherapy, radiation therapy or biological t...
Crohns Disease
Crohn’s disease or regional enteritis is an inflammatory bowel disease that involves the small intes...
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by c...
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....
Radiation Hazards
Ionizing radiation can damage living tissue in the human body. It strips away electrons from atoms b...
Radiotherapy
A detailed account of radiation, its mode of action, side effects and dosage in the treatment of ......
X-Ray
Encyclopedia section of medindia gives a brief Overview of X-Ray  ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use